While Ozempic and other GLP-1 medications contain different active molecules and carry distinct brand names, they allegedly cause the same types of severe gastrointestinal complications
In contrast, broad-spectrum SSP inhibitors carry a higher risk of toxicity due to interference with normal tissue metabolism, necessitating optimization via targeted delivery technologies (136, 137)
For those seeking maximum efficacy, PlexusDx offers GLP-Squared, a dual-compound injection combining semaglutide and tirzepatide, at $289/mo month-to-month, or from $249/mo on the 6-month plan
Helps improve skin radiance and luminosity
PMCID: PMC4691133
Findings below: Although GLP-1 initiation reduces spending on other diabetes medications, total non-GLP-1 spending increases, driven by higher outpatient health care use